Members
Dr Christopher John BRACKMAN
Prof. CHAN Kay-sheung, Paul
Dr CHAN Kin-sang, J.P.
Dr CHUANG Shuk-kwan, J.P.
Dr Vivien CHUANG
Dr KWONG Fung Ming, Jasmine
Dr LAI Wai-man, Raymond
Dr LUI Chung-yan, Grace
Prof. Joseph Sriyal Malik PEIRIS, S.B.S.
Dr TSANG Yin-chau, Benedict
Dr WU Tak-chiu
Dr YEUNG Lee, Michelle

Scope of Advice

1. To advise the Controller, CHP on scientific basis of the public health actions aimed at protecting the community from emerging and zoonotic diseases; and
2. To review and develop strategies for public health management of emerging and zoonotic diseases and their risk factors in the light of changing epidemiology and advances in medical science.

Papers Discussed / Recommendations

• Consensus Interim Recommendations on Use of COVID-19 Vaccines in Hong Kong (As of 17 July 2024)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 20 February 2024)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 11 October 2023)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 June 2023)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 29 March 2023)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 1 December 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 13 October 2022)

• Consensus Interim Recommendations on the Use of Monkeypox Vaccines in Hong Kong (As of 15 September 2022)

• Consensus Interim Recommendations on Co-administration of COVID-19 vaccine with other vaccines in Hong Kong (As of 11 August 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 1 August 2022)

• Consensus Interim Recommendations on the Use of Monkeypox Vaccines in Hong Kong (As of 16 June 2022)

• Consensus Interim Recommendations on the Use of Comirnaty COVID-19 Vaccines in Hong Kong (As of 16 June 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 19 May 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 April 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Persons with Previous COVID-19 Infection and Children in Hong Kong (As of 12 March 2022) 
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 25 February 2022)(Updated on 12 Mar 2022) 
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Children in Hong Kong (As of 17 January 2022) 
• Consensus Interim Recommendations on the Use of Comirnaty Vaccine in Hong Kong (As of 23 December 2021)
• Consensus Interim Recommendations on the Use of CoronaVac vaccine in children and adolescents in Hong Kong (As of 19 November 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 27 October 2021)(Updated on 19 Nov 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 15 September 2021)
• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Inbound Travellers (As of 16 August 2021)
• Updated Consensus Recommendations on Criteria for Releasing Confirmed COVID-19 Patients from Isolation (As of 4 August 2021) 
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 22 July 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 9 June 2021)
• Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Inbound Travellers(As of 9 June 2021)
• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 9 June 2021)
• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 13 May 2021)
• Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 6 May 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 May 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of April 22 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of March 18 2021)
• Consensus Interim Recommendations on the Use of CoronaVac in Hong Kong (As of February 19 2021)(Updated on 19 Nov 2021)
• Consensus on the Use of BNT162b2 among Frail Elderly in Hong Kong (As of 8 February 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of Jan 7 2021)
• Updated Consensus Recommendations on Criteria for Releasing Confirmed COVID-19 Patients from Isolation on July 29, 2020 (July 2020)
• Updated Consensus Recommendations on Criteria for Releasing Confirmed COVID-19 Patients from Isolation (July 2020)
• Consensus Recommendations on COVID-19 and SARS-CoV-2 made during the meeting held on May 6,2020 (May 2020)
• Consensus on the Use of Surgical Mask by the General Public in Public Places (February 2020)
• Recommendations on prevention and control of novel coronavirus infection made during the joint meeting held on February 17, 2020 (Feb 2020)
• Recommendations on prevention and control of novel coronavirus infection made during the joint meeting held on January 24, 2020 (Jan 2020)
• Summary of Recommendations for Prevention and Control of Community-Associated Methicillin-Resistant Staphylococcus aureus in Hong Kong (May 2017)
• Recommendation on Control of the Risk of Transmission of Avian Influenza to Humans in the Long Term (July 2016)
• Consensus Summary of Recommended Strategy for Prevention and Control of Legionnaires' Disease in Hong Kong (December 2015)
• Summary of Recommendations on Management of Close Contacts of Cases of Human Infection with Avian Influenza in Hong Kong (March 2015)
• Consensus Summary on Ebola Virus Disease (EVD) (October 2014)
• Consensus Summary on Middle East Respiratory Syndrome (October 2014)
• Consensus Summary on Avian Influenza A (H7N9) (October 2014)
• Summary of Recommendations on Antiviral Stockpiling for Influenza Pandemics (October 2014)
• Consensus Summary on Ebola Virus Disease (EVD) (August 2014)
• Consensus Summary on Middle East Respiratory Syndrome (March 2014)
• Consensus Summary on Avian Influenza A (H7N9) (March 2014)
• Consensus Summary on Middle East Respiratory Syndrome (August 2013)
• Consensus Summary on Avian Influenza A (H7N9) (April 2013)
• Recommendations on Influenza H5N1 Pre-pandemic and Pandemic Vaccines (December 2012)
• Consensus Summary on Severe Respiratory Disease associated with Novel Coronavirus (September 2012)
• Statement on Scarlet Fever (June 2011)
• Recommendations on Human Swine Influenza (HSI) Vaccination (January 2010)
• Update of epidemiology of community-associated methicillin resistant Staphylococcal aureus (CA-MRSA) infection in Hong Kong (December 2007)
• Epidemiology of Creutzfeldt-Jakob Disease in Hong Kong (December 2007)
• Avian Influenza Situation Updates (December 2007)
• General guide to doctors: antiviral use for novel influenza treatment and prophylaxis (December 2007)
• A review of community-associated methicillin resistant staphylococcal aureus (CA-MRSA) cases in Hong Kong (June 2007)
• Suspension Period of Live Poultry Supply from the Mainland (August 2006)
• Recommendations To Reduce Risk of H5N1 Avian Influenza Infection (February 2006)
• Latest Development in Avian Influenza (December 2005)
• Streptococcus suis infection in Hong Kong (November 2005)
• Prevention and Control of Rabies (June 2005)
• Avian influenza H5N1: Assessing the current risk of human-to-human transmission (March 2005)
• Review of surveillance systems for detecting clusters of unusual diseases in Hong Kong and other countries (March 2005)
• Summary of Recommendations on Antiviral Stockpiling for Influenza Pandemics (March 2005)
• Avian Influenza (H5N1) in Southeast Asia Region (November 2004)